Correction to: J Exp Clin Cancer Res (2019) 38:40
https://doi.org/10.1186/s13046-019-1031-4
In the original publication of this manuscript [1], the author mislabeled the CTL group and ZNF326 group in Fig.2-I,J (MTT result). The revised Fig. 2 is shown below.
Fig. 2.
Impact of ZNF326 expression on the proliferation and invasiveness of glioma cells in vitro. ZNF326 overexpression significantly enhanced the colony formation (a, b), invasiveness (e, f, magnification-400×), and proliferation (i, j) of U87 and U251 glioma cell lines. Conversely, ZNF326 knockdown significantly inhibited colony formation (c, d), invasiveness (g, h, magnification-400×), and proliferation (k, l) of U87 and U251 glioma cell lines. CTL: control group. Each experiment was performed in triplicate. Columns: mean numbers. Bars: S.D. (*: P < 0.05; **: P < 0.01; ***: P < 0.001)
The authors sincerely apologize for the inconvenience caused to the readers.
Reference
- 1.Yu X, et al. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway. J Exp Clin Cancer Res. 2019;38:40. doi: 10.1186/s13046-019-1031-4. [DOI] [PMC free article] [PubMed] [Google Scholar]